MetLife Investment Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-20,346
| Closed | -$701K | – | 2350 |
|
|
2020
Q3 | $701K | Hold |
20,346
| – | – | 0.01% | 1206 |
|
|
2020
Q2 | $340K | Hold |
20,346
| – | – | ﹤0.01% | 1592 |
|
|
2020
Q1 | $293K | Hold |
20,346
| – | – | ﹤0.01% | 1486 |
|
|
2019
Q4 | $681K | Hold |
20,346
| – | – | 0.01% | 1291 |
|
|
2019
Q3 | $426K | Hold |
20,346
| – | – | ﹤0.01% | 1510 |
|
|
2019
Q2 | $424K | Hold |
20,346
| – | – | ﹤0.01% | 1582 |
|
|
2019
Q1 | $455K | Hold |
20,346
| – | – | ﹤0.01% | 1509 |
|
|
2018
Q4 | $487K | Hold |
20,346
| – | – | 0.01% | 1385 |
|
|
2018
Q3 | $555K | Hold |
20,346
| – | – | 0.01% | 1471 |
|
|
2018
Q2 | $547K | Buy |
20,346
+3,261
| +19% | +$87.7K | 0.01% | 1361 |
|
|
2018
Q1 | $544K | Hold |
17,085
| – | – | 0.01% | 1324 |
|
|
2017
Q4 | $646K | Buy |
+17,085
| New | +$646K | 0.01% | 1253 |
|